Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT00979745 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG: Afamelanotide
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited